Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.
about
Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitisGabexate mesylate as treatment in the course of ANCA-negative microscopic polyangiitis.Clinical Predictors of Outcome in Patients with Anti-neutrophil Cytoplasmic Autoantibody-related Renal Vasculitis: Experiences from a Single-center.Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort studyThe CD4 Lymphocyte Count is a Better Predictor of Overall Infection Than the Total Lymphocyte Count in ANCA-Associated Vasculitis Under a Corticosteroid and Cyclophosphamide Regimen: A Retrospective Cohort.Key advances in the clinical approach to ANCA-associated vasculitis.Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis.Lymphopenia, Infectious Complications, and Outcome in Spontaneous Intracerebral Hemorrhage.Vasculitis for the internist: focus on ANCA-associated vasculitis.Infectious complication or exacerbation of granulomatosis with polyangiitis?Association of Low B Cell Count and IgG Levels With Infection, and Poor Vaccine Response With All-Cause Mortality in an Immunosuppressed Vasculitis Population.Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.Unmet Needs in the Pathogenesis and Treatment of Vasculitides.Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis.Pediatric Nephrology and Rheumatology Practice Patterns in Granulomatosis with Polyangiitis: A Midwest Pediatric Nephrology Consortium Study
P2860
Q26751357-EA1D5597-8933-4698-83BD-68DD9BADE8F8Q33406896-ED419465-87FC-4B33-B672-9924FEFD2A11Q33608983-3558C147-E6FC-4AA5-A19B-BF02AAE29F5EQ33767030-41517706-3313-4CDB-9E76-98947E0E3E63Q36151396-A3C9E2C3-8AC6-4B01-8FDF-C047473B6FA6Q38224803-D02979FC-1279-45C7-B5EC-DB84F674FE83Q38334787-A741648B-C01F-419B-92F3-17EFD75893DCQ39048354-40A810FF-BABD-4BF1-ABF4-520781D6D29BQ39379384-DA48602C-0168-4BB9-8D06-42E083B40F74Q40697375-FEE2A90B-A3F4-481D-961B-4C29541069E2Q40948863-FB60B7A6-B2A0-468C-BD1B-CC4C9ACC794DQ46609151-FEA545A2-BFEB-4FD0-9DFF-2B0DC43BF832Q48592090-CC476E28-B4EF-4078-B3B4-7276E1D2868CQ55191066-EBA8F187-C705-4D93-8515-345076B0817BQ58800147-18B5FDA8-64FC-4121-8E6D-DD4EC1CC9A27
P2860
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.
@ast
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.
@en
type
label
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.
@ast
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.
@en
prefLabel
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.
@ast
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.
@en
P2093
P2860
P356
P1476
Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.
@en
P2093
Annie-Claire Nadeau-Fredette
Clément Déziel
Rémi Goupil
Soumeya Brachemi
Stéphan Troyanov
Valery Lavergne
Yves Troyanov
P2860
P304
P356
10.2215/CJN.07300712
P577
2012-12-06T00:00:00Z